<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T04:52:04Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/17067" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/17067</identifier><datestamp>2026-10-18T20:56:43Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Protective effect of daidzein on ovarian ischemia-reperfusion injury in rats</dc:title><dc:creator>Toktay, Erdem</dc:creator><dc:creator>Gurbuz, Muhammet Ali</dc:creator><dc:creator>Bal, Tugba</dc:creator><dc:creator>Ozgul, Ozlem</dc:creator><dc:creator>Erba, Elif</dc:creator><dc:creator>Ugan, Rustem Anil</dc:creator><dc:creator>Sell, Jale</dc:creator><dc:subject>Daidzein</dc:subject><dc:subject>ovary</dc:subject><dc:subject>ischemia-reperfusion injury</dc:subject><dc:subject>rat</dc:subject><dc:subject>ISCHEMIA/REPERFUSION INJURY</dc:subject><dc:subject>ANTIOXIDANT ACTIVITY</dc:subject><dc:subject>ISOFLAVONES</dc:subject><dc:subject>MECHANISMS</dc:subject><dc:subject>METABOLITES</dc:subject><dc:subject>EXPRESSION</dc:subject><dc:subject>APOPTOSIS</dc:subject><dc:subject>CYTOKINES</dc:subject><dc:subject>LIVER</dc:subject><dc:subject>Medicine, General &amp; Internal</dc:subject><dc:subject>General &amp; Internal Medicine</dc:subject><dc:description>Purpose: In this study, our aim was to investigate the potential effects of strong antioxidant daidzein (DZ) on ovarian ischemia and reperfusion injury. Materials and Methods: A total of 42 female Sprague-Dawley rats were randomly divided into seven groups. For the experimental model, the clamps were removed after 3 hours of ischemia, and blood flow was provided again. Then, reperfusion process was terminated for 3 hours. Daidzein was orally administered to animals at doses of 35 and 70 mg/kg 30 minutes before ischemia (I) and ischemia and reperfusion (I/R) procedures. Results: Severe immunoreactivity of the IL-1 beta, IL-6 and Caspase-3 were detected in I and I/R groups. Moderate immunoreactivity of IL-1 beta, IL-6 and Caspase-3 was detected in I+DZ35 and I/R+DZ35 groups, and slightly positivity was detected in I+DZ70 and I/R+DZ70 groups. The SOD activity level increased in the groups treated with Daidzein, while MDA levels decreased. In addition, hemorrhage areas and inflammatory cell migration decreased in I/R+DZ70 and I/R+DZ35 groups, when compared to I/R group in a dose dependent manner. Conclusion: Daidzein has a strong protective role in the treatment of ovarian ischemia-reperfusion injury and can be used as a therapeutic agent.</dc:description><dc:publisher>CUKUROVA UNIV, FAC MEDICINE</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/17067</dc:identifier><dc:identifier>https://doi.org/10.17826/cumj.993250</dc:identifier><dc:identifier>2602-3032</dc:identifier><dc:language>en</dc:language><dc:relation>CUKUROVA MEDICAL JOURNAL</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/17067</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>